WaveMan
WaveMan · Company
YCBD · Cbdmd, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

YCBD cbdMD (YCBD) Insider Trading, Ownership & Congress Trades

Consumer Goods · Perfumes, cosmetics & other toilet preparations · CIK 0001644903
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
8
13F, latest reported quarter

cbdMD insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for cbdMD, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
SELL
2025-12-19 SECtraded 2025-12-17
69,875
$163.5K
-73.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 122.9% of the 56,875 shares held after it.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $163.5K of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
SELL
2025-12-19 SECtraded 2025-12-17
19,101
$44.7K
-73.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 106.9% of the 17,875 shares held after it.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $44.7K of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
SELL
2025-12-19 SECtraded 2025-12-17
461,725
$1.1M
-73.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 127.8% of the 361,400 shares held after it.
  • No other insider sold within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Crosnoe Clark R. sold about $1.1M of YCBD on Dec 17, 2025, the largest insider sale at the company on our record; 8 funds added in the latest 13F quarter.
Interim CEO and CFO
BUY
2023-05-05 SECtraded 2023-05-03
5,000
$10.5K
-97.7%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 24, 2021.
  • The trade is 77.4% of the 6,462 shares held after it.
  • No other insider bought within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Interim CEO and CFO Kennedy Thomas Ronan bought about $10.5K of YCBD on May 3, 2023, the largest insider purchase at the company since 2021; 8 funds added in the latest 13F quarter.
BUY
2021-08-25 SECtraded 2021-08-24
7,400
$15.1K
-100.0%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 7,400 shares held after it.
  • No other insider bought within 30 days.
  • 8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO & COO Kennedy Thomas Ronan bought about $15.1K of YCBD on Aug 24, 2021, the largest insider purchase at the company on our record; 8 funds added in the latest 13F quarter.
6 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 1 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
8 funds bought in last quarter
below 87% of Consumer Goods
Revenue
-3.7% year over year
below 68% of Consumer Goods
Margin
-10.6% net margin
below 75% of Consumer Goods
Buybacks
no share repurchases reported
Short interest
5.0% of the float short (float per yahoo 2026-10-27) · 5.4 days to cover · settled 2026-10-15
more than 64% of Consumer Goods
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch YCBD

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-64.4%12M
-67%-5%+57%+118%2025-102025-122026-022026-042026-062026-082026-10 2025-12-17 · Crosnoe Clark R. sold $1.1M2025-12-17 · Crosnoe Clark R. sold $163.5K2025-12-17 · Crosnoe Clark R. sold $44.7K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns YCBD: institutional holders (13F)

13F holdings, latest reported quarter
137,621 sh
$92.6K
$54.7K

Congress trades in YCBD

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

YCBD planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

YCBD mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
VANGUARD EXTENDED MARKET INDEX FUND
$80.5K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$889 position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 8 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

YCBD financials

Revenue growth
-3.7%
XBRL, annual
Net margin
-10.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$20.9M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-13.8%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$2.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.00x
long-term debt only, 2023-12-31 (30 months older than the period end); equity 2026-06-30
Cash flow to debt
n/a
no debt to cover
Return on equity
-40.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-25.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-35.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
$2.0M
market value at close 2026-10-27 on 2026-08-13 shares, plus long-term debt only, 2023-12-31 (30 months older than the period end), minus cash 2026-06-30
FCF yield
-58.1%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-092024-092023-092022-09
Revenue$19.2M$19.9M$25.1M$37.1M
Gross profit$12.0M$12.0M$15.0M$22.3M
Operating income-$2.2M-$3.3M-$22.5M-$78.3M
Net income-$2.0M-$3.7M-$22.9M-$70.1M
EPS (diluted)-1.09-14.29-13.32-55.80
Operating cash flow-$1.5M-$352.8K-$4.3M-$15.0M
Cash$2.3M$2.5M$1.8M$6.7M
Long-term debtn/an/a$9$125.5K
SEC XBRL, fiscal years, as known on 2026-10-28

YCBD Stock Sonar score 5/7 axes

Find similar shapesCompare

YCBD ranks highest on financial health (99th percentile) and risk and compliance (51st), and lowest on institutional and government (13th), among Consumer Goods peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
14
Inputs
  • Return on equity-40.3% · 13 pct, sector of 105
  • Return on assets-25.1% · 18 pct, sector of 124
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-35.5% · 9 pct, sector of 108
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 112
  • Cash flow to debtno debt to cover
Growth
32
Inputs
  • Revenue growth, YoY-3.7% · 32 pct, sector of 145
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
13
Inputs
  • Funds adding, latest quarter8 · 13 pct, sector of 123
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
51
Inputs
  • Short interest, % of float+5.0% · 46 pct, sector of 159
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+12.0% · 56 pct, sector of 111
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing